Rotary International Global Hepatitis Elimination Programs

logo

Rotary International Global Hepatitis Elimination Programs

Virus
Hepatitis B
Hepatitis C
Type
Implementation
Technical assistance
Setting
Global
Other targets
HIV
Phase
Active
Health outcomes
Prevalence
WHO region
African Region
Region of the Americas
South-East Asia Region
Western Pacific Region
Country
Brazil
Mongolia
India
Mexico
Papua New Guinea
Sri Lanka
Uganda
Nigeria
South Africa
Bahamas
Key interventions
Blood safety
Community mobilization
Hepatitis B Vaccination
Prevention mother-child transmission
Testing and diagnosis
Treatment (direct or referral)
Target population
Adolescents (10 - 19 years of age)
Adults (> 19 years of age)
All ages (infection control and blood banking)
Birth cohorts of adults
Men who have sex with men
Persons who inject drugs
Pregnant women
Performance target
Care cascade: Evidence of current infection
Care cascade: HBV diagnosis
Care cascade: HBV testing
Care cascade: HBV treatment
Care cascade: HCV diagnosis
Care cascade: HCV testing
Care cascade: HCV treatment
Care cascade: Referred for treatment
Hepatitis B vaccination coverage

Health outcomes additional info

Level of specificity varies by country. Technical partners house data; RI currently has no M+E capacity at HQ. All program data sits at project sites

Summary and objectives

Global and National Advocacy, Social Mobilization, Vaccine Purchase, Surveillance Systems, Vaccine delivery, Screening Diagnostic, Referral and Treatment Services, Purchase of Medical Equipment

Rotary International maintains Strategic Partnerships with CDC, WHO, UNICEF and the Bill & Melinda Gates Foundation for its sole corporate program of Global Polio Eradication.

Rotary International funds all hepatitis elimination related projects through The Rotary Foundation’s global grants program. Rotary partners for these programs at the country level with the National Ministries of Health and collaborating NGOs.

Last updated